ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

10,509Medicare Part D Prescriptions Filled, Including Refills
$755K Total Retail Price of All Prescriptions
653 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
18% Subsidized Claims for Low-Income Patients

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume .

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category
CARVEDILOL 840 731
ATORVASTATIN CALCIUM 794 709
AMLODIPINE BESYLATE 522 498
FUROSEMIDE 495 441
CLOPIDOGREL 437 378
SIMVASTATIN 364 340
LEVOTHYROXINE SODIUM 322 308
LISINOPRIL 313 265
PLAVIX 300 273
AMIODARONE HCL 293 282
CRESTOR 288 251
LOSARTAN POTASSIUM 279 261
SPIRONOLACTONE 262 200
PRADAXA 229 229
DIGOXIN 219 188
WARFARIN SODIUM 213 205
ATENOLOL 190 163
METOPROLOL SUCCINATE 184 167
ZETIA 170 163
POTASSIUM CHLORIDE 144 125
HYDROCHLOROTHIAZIDE 140 136
ISOSORBIDE MONONITRATE ER 124 117
LIPITOR 119 103
SPIRONOLACTONE-HCTZ 117 95
PACERONE 114 106
LOSARTAN-HYDROCHLOROTHIAZIDE 109 100
DIOVAN HCT 108 104
XARELTO 99 98
METFORMIN HCL 98 96
DIOVAN 86 84
VERAPAMIL ER 84 84
PRAVASTATIN SODIUM 82 63
NITROSTAT 75 69
RANEXA 66 38
RAMIPRIL 65 65
TEKTURNA 60 58
PROPAFENONE HCL 58 57
JANUVIA 52 51
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.